A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
Clinical trial NCT06052267 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06052267
- Sponsor
- Teva Branded Pharmaceutical Products R&D LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-30
- Primary completion
- 2026-10-31
- Enrollment
- 2772
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.